LSI is Officially Heading to Singapore — Register for LSI Asia '25 Today

April Emerging Medical Technologies Report

Published January 2013 | 15 Pages | 25 Exhibits |


Order individually or subscribe and get a complete intel platform.


This report includes details on 25 emerging medical technology companies that have been identified by LSI's in-house research team in April 2013.

All companies include technology, market(s), key executive, and contact information.

Coverage includes innovations in a broad spectrum of medical technology areas including:
- Aesthetics/Dermatology Companies
- Biomaterials Companies
- Biotechnology/Cell Therapy Companies
- Cardiovascular Companies
- Dental Companies
- Diagnostics Companies
- Drug Delivery Companies
- Endocrine Companies
- Gastroenterology Companies
- Gynecology/Women's Health Companies
- Imaging Companies
- Neurology Companies
- Oncology Companies
- Ophthalmology Companies
- Orthopedics Companies
- Pain Management Companies
- Patient Management/Monitoring Companies
- Pharmaceutical Companies
- Respiratory Companies
- Spine Companies
- Surgery Companies
- Urology Companies
- Vascular Companies
- Wound Management Companies

This report is included in LSI's Emerging Medical Technologies® Database.

Table of Contents


•1-Femtosecond laser-based workstation for ophthalmic surgery on the crystalline lens, such as cataract surgery; 2-A patented presbyopia reversal procedure; and 3-Products for tissue and cell handling in pharma, biotech, and research
•1-Non-invasive molecular diagnostic assay to diagnose color blindness far more accurately and thoroughly than existing tests and 2-Gene therapy to treat color blindness
•A unique disposable Peristaltic Feeding Tube (PFT) that is monitored and controlled 24/7 by a bedside Control & Monitoring Unit (CMU), capable of preventing reflux, and expected to significantly lower the occurrence of VAP (Ventilator Associated Pneumonia) in ventilated patients
•Arterial puncture closure device that achieves closure by applying a biocompatible implant to both the inside and the outside of the puncture site in the femoral artery at the level of the arterial wall
•Bioabsorbable vascular closure technologies for large diameter interventional procedures
•Compact, microchip-based optical coherence tomography (OCT) system that can produce dynamic, real-time, high-resolution diagnostic images for physicians to perform a non-invasive optical "digital biopsy" of tissues
•Compounds for the treatment of amyotrophic lateral sclerosis (ALS), Huntington's disease (HD), epilepsy, and neuropathic pain
•Device that determines real-time and exact liver function measurement at the patient's bedside via simple breath analysis
•Disruptive implants that allow a natural spine balance after surgery through a dynamic fusion philosophy with the goal of improving the functional outcome and avoiding adjacent level degeneration
•Drugs based on technology which emulates human physiology and predicts clinical outcomes upfront
•Drugs utilizing a proprietary platform based on the atomic interaction network analyses of proteins to prevent and treat infectious and other major diseases
•Female sterilization device that can be implanted hysteroscopically in a gynecologist's office and provide immediate closure of the fallopian tubes, with no need for continued use of other contraceptives nor any confirmatory procedures at a follow-up visit
•New classes of medicines that have unique modes of action to result in drugs with differentiated therapeutic properties
•New modality for the management of COPD symptoms using an innovative and proprietary pressure pulses protocol carried into the lungs over a low-pressure airstream
•Next-generation "mini" ventricular assist device (VAD) with a fundamentally different layout to minimize blood damage and the risk of thrombus formation, at a significantly reduced cost per pump
•Next-generation implantable electrodes for Deep Brain Stimulation (DBS) in major neurological indications such as Parkinson's disease (PD) and depression
•Next-generation surface treatments for dental and orthopedic implants
•Non-invasive Magnetic Resonance-guided Focused Ultrasound (MRgFUS) technology as a treatment alternative to invasive procedures, for a wide variety of applications
•Non-invasive neurostimulation platform for specific medical indications, beginning with nicotine and narcotic addictions
•Non-invasive Transcutaneous Electrical Nerve Stimulator (TENS) device indicated for symptomatic relief and management of chronic, intractable pain, and adjunctive treatment in the management of post-surgical and post-traumatic pain
•Novel access stabilization and closure device to facilitate the transapical delivery of prosthetic heart valves, left ventricular assist devices (LVADs), and other large therapeutic devices
•Pedicle-screw-based posterior elastic stabilization system that is intended to work like a damper, absorbing shocks, unloading the disc and facet joints
•Range of high-quality calibrators, proficiency sera, and liquid stable quality controls for the clinical diagnostics market
•Stenting solutions for coronary and vascular systems, bifurcation stenting, and biliary stenting
•System that combines the best of low-dose X-rays and automated ultrasound to enhance a clinician's ability to detect breast cancer

Work with us

Accelerate your business

We’re here to help you make smarter decisions and form stronger partnerships through curated events, independent market intelligence products and services, and digital-forward media.